next message in archive
no next message in thread
previous message in archive
Index of Subjects
This is a MIME Message
------=_NextPart_000_007F_01BDF6C7.FABAC1B0
Content-Type: multipart/alternative; boundary="----=_NextPart_001_0080_01BDF6C7.FABAC1B0"
------=_NextPart_001_0080_01BDF6C7.FABAC1B0
Content-Type: text/plain; charset="iso-8859-1"
Content-Transfer-Encoding: quoted-printable
***** This is an HTML Message ! *****
------=_NextPart_001_0080_01BDF6C7.FABAC1B0
Content-Type: text/html; charset="iso-8859-1"
Content-Transfer-Encoding: quoted-printable
<head>
<title></title>
</head>
<body bgcolor=3D"#003366">
<p align=3D"center"> =
<font color=3D"#FFFF00" size=3D"5"><b>STOCKS ARE DOWN ACROSS THE BOARD</b>=
</font><br>
<br>
<font size=3D"3" color=3D=
"#FFFFFF">Where can the sophisticated investor go for returns that beat the=
market?</font><br>
<br>
<br>
<font size=3D"5"> <font color=3D=
"#FFFF00"><b>THE BIOTECH SECTOR IS STILL HOT!</b></font></font><br>
<br>
<br>
<font size=3D"5" color=3D"#FFFF00"><b>Consider this=2E=2E=
=2E</b></font></p>
<p align=3D"left"> </p>
<p align=3D"left"><font size=3D"3" color=3D"#FFFFFF">January 2 =96 CBS Mar=
ketWatch - "Analyst Mark Augustine at USB Piper Jaffray believes 2002<br>
will be a strong year for the biotechnology sector due to impro=
ving industry fundamentals and a<br>
favorable market and economic environment=2E He also feels merg=
er speculation could hit<br>
development-stage companies=2E"<br>
<br>
<br>
December 24 - Washington Post - "As investors look for new plac=
es to park their money, biotech<br>
firms are grabbing a larger share of a shrinking pool of ventur=
e capital=2E=2E=2E What we=92re seeing is a<br>
greater interest in the life sciences sector than any other sec=
tor" <br>
<br>
<br>
Recent progress by genetic researchers worldwide, including the=
well-known Human<br>
Genome Project's effort to map the human genome, has grabbed th=
e world's attention<br>
with its vast possibilities and made it a very attractive field=
for speculative investors=2E</font></p>
<p align=3D"center"><b><font size=3D"5" color=3D"#FFFF00">Many experts agr=
ee that the future of medicine is in<br>
genomic research=2E=2E=2E=2E <=
/font></b></p>
<p align=3D"left"><font size=3D"3" color=3D"#FFFFFF">Millions of people di=
e each year from disease and thousands more die from negative<br>
responses to drugs=2E The science of genomics promises to impro=
ve lives by (1)<br>
identifying the genes that cause disease so doctors can attack =
a disease before<br>
symptoms ever become visible, and (2) determining which drugs s=
hould be prescribed<br>
to a person based on their unique genetic make-up=2E </fon=
t></p>
<ul>
<li style=3D"color: #FFFFFF">
<p align=3D"left"><font size=3D"3" color=3D"#FFFFFF">The entire pharma=
ceutical industry has developed drugs against only about 500<br>
genes=2E If 200 common diseases are each caused by 50 diff=
erent genes, there<br>
may be 10,000 disease genes out there, so the vast majorit=
y of the disease<br>
genes will not have existing drugs to combat them=2E =
<br>
</font></li>
</ul>
<p align=3D"center"><font size=3D"5" color=3D"#FFFF00">Would you be intere=
sted in jump-starting your <br>
portfolio with an aggressive Biotech investment?&nb=
sp;</font></p>
<ul style=3D"color: #FFFFFF">
<li>
<p align=3D"left">Led by a Harvard-trained Ph=2ED=2E, a new developmen=
t-stage company is taking<br>
advantage of the recent advances in genomics and informati=
on technology to<br>
solve as many common diseases as possible within the next =
five years by<br>
identifying as many of the genes as possible which contrib=
ute to a specific<br>
disease=2E <br>
</li>
<li>
<p align=3D"left">The Company's goal is nothing short of a medical rev=
olution: they aim to<br>
change the way medicine is practiced=2E Instead of waiting=
for symptoms to <br>
develop, they intend to diagnose disease before any signs are visible<=
br>
</li>
<li>
<p align=3D"left">They already own three potentially blockbuster clini=
cal provisional patents that<br>
are ready for immediate licensing=2E <br>
</li>
<li>
<p align=3D"left">It is estimated by Daniel Cohen of Genset that a sin=
gle disease gene is worth<br>
from 40 to 80 million dollars=2E This new company expects=
to find hundreds of<br>
these=2E<br>
</li>
<li>
<p align=3D"left"> It is estimated by Daniel Cohen of G=
enset that a single disease gene is worth<br>
from 40 to 80 million dollars=2E This new company expects=
to find hundreds of<br>
these=2E<br>
</li>
<li>
<p align=3D"left">The company just received an infusion of $2M in vent=
ure capital and began<br>
trading less than two months ago=2E This is truly a groun=
d floor opportunity=2E=2E<br>
</li>
<li>
<p align=3D"left">The company's stated goal is to be bought out for a =
minimum of $100M or get<br>
listed on the NASDAQ Small Cap or NASDAQ National Market S=
ystems<br>
Exchange=2E Either of these outcomes should be a boon to t=
he Company's<br>
shareholders=2E <br>
<br>
<br>
</li>
</ul>
<p align=3D"center"><font size=3D"5" color=3D"#FFFF00"><b>Want to find out=
more?</b></font></p>
<p align=3D"center"><font size=3D"5" color=3D"#FFFF00"><b>Please enter you=
r email
address in the box below and hit the submit to request a free report=
on this exciting opportunity=2E</b></font></p>
<form name=3D"form"
method=3D"post"
action=3D"mailto:ksddk@verizonmail=2Ecom?SUBJECT=3DFree Report"
enctype=3D"text/plain"
<p align=3D"center">
<p align=3D"center"><input type=3D"text" name=3D"EMAIL_ADDRESS" size=3D"=
20">
<p align=3D"center"><input type=3D"submit" value=3D"Submit" name=3D"B1">=
<input type=3D"reset" value=3D"Reset" name=3D"B2"></p>
</form>
<p align=3D"center"> </p>
<p align=3D"left"><font color=3D"#FFFFFF" size=3D"1"><b>Disclaimer:</b></f=
ont> <font size=3D"2" color=3D"#FFFFFF"> The contents of this mailing are p=
rovided for informational purposes only=2E Information in this mailing has =
been obtained from publicly available sources deemed
to be reliable, but the Sender makes no guarantee as to the accuracy or c=
ompleteness of this data=2E Under no circumstances does the information in =
this mailing represent a
recommendation to buy or sell securities of any kind=2E Information is pro=
vided for informational purposes only, and Sender shall not be liable for a=
ny errors or omissions, or
for any actions taken in reliance thereon=2E Sender was compensated 400,0=
00 shares of stock in the above company by a third party to provide corpora=
te exposure services,
including the distribution of this mailing=2E </font></p>
<p align=3D"center"> <b><font size=3D"4" color=3D"#FF0000">List
Removal/OPT-OUT Option</font></b>
<br><b><a
href=3D"mailto:hbkmkp@netscape=2Enet?subject=3Dremove"><font size=3D"3" c=
olor=3D"#FFFFFF">Click
Here</font></a></b></p>
</body>
------=_NextPart_001_0080_01BDF6C7.FABAC1B0--
------=_NextPart_000_007F_01BDF6C7.FABAC1B0--
next message in archive
no next message in thread
previous message in archive
Index of Subjects